KYinno
Beijing
About KYinno
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $60.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: kyinno.com
- Phone: 086-010-58222701
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/kyinno-36039 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.